Novel biophotonics platform for scalable C. elegans health data
Our patented biophotonics platform analyses and captures multiple end-point data from living worms, providing rich integrated measures on the effect of your compound or product. In contrast to manual assays, that are well-established in academic research to measure health, ageing, toxicity (death) and disease in C. elegans, our WormGazerTM Technology confers several advantages:
See our recent paper showing how WormGazer™ matches the data from a 40-day manual lifespan data in just 7 days
Over 80+ years of world-leading expertise in C. elegans research, combined with our WormGazerTM Technology ensures all aspects of our assays are conducted with the utmost consistency. Our automated approach is optimal for standardised data acquisition with a non-invasive approach. For example, there are no abrupt changes in lighting or temperature, or mechanical disruption to our worm cultures.
Unlike competitors, our technology enables us to maintain worms in a more natural, free-moving environment (as opposed to microchips), to encourage native behaviour and reliable data outcomes. In addition, WormGazerTM Technology allows continuous data acquisition with multiple culture plates per test conditions. Tracking images are taken every 0.8 sec for 160 secs, every 5 mins 24 hrs a day with an extensive duration (up to 14 days). As a result, we can generate a petabyte of relevant data per week. This allows us to reliably detect small changes between test conditions to provide information about whether your product has a tight efficacy window and understand the complexity of dose responses. This rich data is customisable for a multi-faceted healthspan approach, enabling you to select diverse and highly relevant end-points for your research — not just single data-point outcomes.
© 2025 Magnitude Biosciences Ltd. All rights reserved.